In addition, RNASeq analysis showed that curcumin treatment inhibited the oncogenic TFAP2A-mediated ECM pathway by negatively regulating the associated genes, including COMP, LAMA5, and ITGA1, wherein TFAP2A expression is associated with poor prognosis in cancer patients [139]. This evidence concerns the gene TFAP2A and cancer.